chr1-99874756-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM5PP3

The NM_000642.3(AGL):​c.1028G>A​(p.Arg343Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000424 in 1,603,240 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R343W) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00045 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 0 hom. )

Consequence

AGL
NM_000642.3 missense

Scores

8
8
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:10B:1

Conservation

PhyloP100: 8.57

Publications

6 publications found
Variant links:
Genes affected
AGL (HGNC:321): (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
AGL Gene-Disease associations (from GenCC):
  • glycogen storage disease III
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Laboratory for Molecular Medicine, Myriad Women’s Health, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-99874755-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 429532.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.811

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGLNM_000642.3 linkc.1028G>A p.Arg343Gln missense_variant Exon 8 of 34 ENST00000361915.8 NP_000633.2 P35573-1A0A0S2A4E4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGLENST00000361915.8 linkc.1028G>A p.Arg343Gln missense_variant Exon 8 of 34 1 NM_000642.3 ENSP00000355106.3 P35573-1

Frequencies

GnomAD3 genomes
AF:
0.000443
AC:
66
AN:
148964
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000727
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000201
Gnomad ASJ
AF:
0.00125
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.000100
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000813
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000422
AC:
106
AN:
251306
AF XY:
0.000442
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000686
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000422
AC:
613
AN:
1454156
Hom.:
0
Cov.:
33
AF XY:
0.000444
AC XY:
321
AN XY:
723428
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33416
American (AMR)
AF:
0.000180
AC:
8
AN:
44498
Ashkenazi Jewish (ASJ)
AF:
0.000548
AC:
14
AN:
25566
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39650
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
85990
European-Finnish (FIN)
AF:
0.000306
AC:
16
AN:
52324
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5684
European-Non Finnish (NFE)
AF:
0.000489
AC:
541
AN:
1107132
Other (OTH)
AF:
0.000284
AC:
17
AN:
59896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000449
AC:
67
AN:
149084
Hom.:
1
Cov.:
33
AF XY:
0.000384
AC XY:
28
AN XY:
72846
show subpopulations
African (AFR)
AF:
0.0000725
AC:
3
AN:
41388
American (AMR)
AF:
0.000201
AC:
3
AN:
14942
Ashkenazi Jewish (ASJ)
AF:
0.00125
AC:
4
AN:
3212
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4790
European-Finnish (FIN)
AF:
0.000100
AC:
1
AN:
9968
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
0.000813
AC:
54
AN:
66390
Other (OTH)
AF:
0.000490
AC:
1
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000708
Hom.:
0
Bravo
AF:
0.000325
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000437
AC:
53
EpiCase
AF:
0.000327
EpiControl
AF:
0.000711

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:10Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:5
Mar 30, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The AGL c.1028G>A; p.Arg343Gln variant (rs137943515), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 445557). This variant is found in the general population with an overall allele frequency of 0.05% (129/282664 alleles) in the Genome Aggregation Database. The arginine at codon 343 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.659). Due to limited information, the clinical significance of this variant is uncertain at this time. -

Oct 21, 2022
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PM2 -

Sep 25, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2020
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -

Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AGL: PM5 -

Glycogen storage disease type III Uncertain:4Benign:1
Jan 07, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 28, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Jul 04, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1028G>A (p.R343Q) alteration is located in exon 8 (coding exon 7) of the AGL gene. This alteration results from a G to A substitution at nucleotide position 1028, causing the arginine (R) at amino acid position 343 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.44
BayesDel_addAF
Benign
-0.057
T
BayesDel_noAF
Uncertain
0.11
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.45
T;T;T;T;.
Eigen
Pathogenic
0.70
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D;.;.;.;D
M_CAP
Uncertain
0.13
D
MetaRNN
Pathogenic
0.81
D;D;D;D;D
MetaSVM
Pathogenic
0.80
D
MutationAssessor
Pathogenic
3.5
H;H;H;H;.
PhyloP100
8.6
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-3.4
D;D;D;D;D
REVEL
Pathogenic
0.66
Sift
Uncertain
0.0040
D;D;D;D;D
Sift4G
Uncertain
0.013
D;D;D;D;D
Polyphen
1.0
D;D;D;D;D
Vest4
0.83
MVP
0.94
MPC
0.31
ClinPred
0.70
D
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.52
gMVP
0.83
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137943515; hg19: chr1-100340312; API